A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2011
08/25/2011	US20110207773 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors
08/25/2011	US20110207772 Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase
08/25/2011	US20110207763 8-carboxamido-2,6-methano-3-benzazocines
08/25/2011	US20110207749 Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase
08/25/2011	US20110207747 2,5-Disubstituted Phenyl Carboxamide Orexin Receptor Antagonists
08/25/2011	US20110207746 New compounds i
08/25/2011	US20110207741 Activation of the Renin-Angiotensin System (RAS) and Sudden Cardiac Death
08/25/2011	US20110207738 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
08/25/2011	US20110207737 Substituted bicyclic amines for the treatment of diabetes
08/25/2011	US20110207734 Azine Derivatives and Methods of Use Thereof
08/25/2011	US20110207732 Azaindole derivatives
08/25/2011	US20110207730 Ion channel modulating compounds and uses thereof
08/25/2011	US20110207721 Purine derivatives as kinase inhibitors
08/25/2011	US20110207718 Compositions and methods for treating psychiatric disorders
08/25/2011	US20110207717 2-aminopyrimidine compounds as serotonin receptor modulators
08/25/2011	US20110207714 Serotonin receptor modulators
08/25/2011	US20110207713 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE
08/25/2011	US20110207711 Therapeutic Compounds
08/25/2011	US20110207710 Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase a2 (spla2) inhibitors and spla2 inhibitor combination therapies
08/25/2011	US20110207709 Modulators of serotonin receptor
08/25/2011	US20110207698 Heteroaryl-substituted dicyanopyridines and their use
08/25/2011	US20110207694 Mammalian hypothalamic nutrient modulation of glucose metabolism
08/25/2011	US20110207662 Composition for Long-Acting Peptide Analogs
08/25/2011	US20110207661 Benzylbenzene derivatives and methods of use
08/25/2011	US20110207224 In vivo production of small interfering rnas that mediate gene silencing
08/25/2011	US20110206787 Morinda Citrifolia and Iridoid Based Formulations
08/25/2011	US20110206786 Acai and Iridoid Based Formulations
08/25/2011	US20110206785 Extract of polygonum multiflorum thunb. ex murray var. hypoleucum and compositions for improving metabolic syndrome
08/25/2011	US20110206766 Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
08/25/2011	US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011	US20110206745 Octreotide implant having a release agent
08/25/2011	US20110206743 Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
08/25/2011	US20110206723 Use of plant cell membrane for the treatment of obesity
08/25/2011	US20110206721 Fermented soy nutritional supplements including mushroom components
08/25/2011	US20110206698 Antagonist anti-il-7 receptor antibodies and methods
08/25/2011	US20110206686 Il-23 antibodies
08/25/2011	US20110206684 Method of producing nutritional products from human milk tissue and compositions thereof
08/25/2011	US20110206668 Methods and compositions for modulating immunity
08/25/2011	US20110206663 Anti-Interferon-Alpha Antibodies
08/25/2011	US20110206652 Methods for treating atherosclerosis
08/25/2011	US20110206646 Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
08/25/2011	US20110206642 Preventing obesity-related metabolic syndrome with melagonesis
08/25/2011	DE102010008981A1 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie A silicon-containing biologically degradable material for pro-angiogenic therapy
08/25/2011	CA2790643A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
08/24/2011	EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof
08/24/2011	EP2360251A2 In vivo production of small interfering RNAs that mediate gene silencing
08/24/2011	EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using
08/24/2011	EP2359855A2 Methods of administering anti-TNFalpha antibodies
08/24/2011	EP2359843A1 Pharmaceutical composition for treating a metabolic syndrome
08/24/2011	EP2359840A1 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy
08/24/2011	EP2359838A1 Preparations and uses thereof for treating fatness and disorders related
08/24/2011	EP2359822A1 Treatment of cachexia
08/24/2011	EP2359700A1 Method for manufacturing foodstuff comprising resistant starch for use in the treatment of metabolic syndrome and products therefrom
08/24/2011	EP2358756A1 High affinity human antibodies to pcsk9
08/24/2011	EP2358717A1 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
08/24/2011	EP2358713A1 Imidazopyridazine derivatives acting as orexin antagonists
08/24/2011	EP2358712A1 Piperidine derivatives useful as orexin receptor antagonists
08/24/2011	EP2358711A1 Piperidine derivatives useful as orexin receptor antagonists
08/24/2011	EP2358438A1 Nutritional compositions with large lipid globule size
08/24/2011	EP2358365A1 Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives
08/24/2011	EP2358200A1 Substituted bicyclic amines for the treatment of diabetes
08/24/2011	EP1948652B1 Glucokinase activators
08/24/2011	EP1758590B1 Use of a detergent for the non-surgical removal of fat
08/24/2011	EP1485353B1 New inhibitors of histone deacetylase
08/24/2011	EP1480962B1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
08/24/2011	EP1465882B1 Hetrocyclic modulators of nuclear receptors
08/24/2011	EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases
08/24/2011	EP1023067B2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
08/24/2011	CN1775289B Multi vitamin oral disintegrating tablet formulation and its preparing method
08/24/2011	CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides
08/24/2011	CN102164900A 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
08/24/2011	CN102164899A 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as FXR modulators against dyslipidemia and related diseases
08/24/2011	CN102164884A Hydroxybutyrate ester and medical use thereof
08/24/2011	CN102164596A Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
08/24/2011	CN102161650A Polyphenol secondary metabolic products in mulberry leaves and preparation method and application thereof
08/24/2011	CN102161644A Ligands for g-protein coupled receptors
08/24/2011	CN102161619A Ferulic acid Jiangtang compound salt as well as preparation method and application thereof
08/24/2011	CN102160889A Extract, composition, and use of overground part of hedychium coronarium koenig
08/24/2011	CN102160862A Antiobesity agent and pharmaceutical, food, or cosmetic provided with fat accumulation inhibiting effect
08/24/2011	CN102160648A Rapidly disintegrating calcium tablets and preparation method thereof
08/24/2011	CN101869660B Capsules for treating chronic fatigue syndrome and climacteric syndrome
08/24/2011	CN101836975B Application of isopentene group flavonoid compound used as pancreatic lipase inhibitor
08/24/2011	CN101690780B Compound drug for treating diabetes and preparation method thereof
08/24/2011	CN101637207B Puer tea pigment with antilipemic activity and application thereof
08/24/2011	CN101612196B Chinese medicinal composition for preventing and curing heart cerebrovascular diseases and use thereof
08/24/2011	CN101468171B Medicament for weight-reducing of fat people and weight-gaining of thin people
08/24/2011	CN101406618B Traditional Chinese medicine mixture for treating diabetes
08/24/2011	CN101327310B Chinese medicinal composition for treating hyperlipemia and preparation thereof
08/24/2011	CN101327246B Radix astragali medicinal materials, intermediate body and method for testing fingerprint of formulation thereof as well as standard fingerprint
08/24/2011	CN101264169B Alcohol-clearing liver nourishing capsule and manufacturing technique
08/24/2011	CN101166706B Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same
08/24/2011	CN101102751B Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
08/24/2011	CN101062947B Ciliary neurotrophy factor polypeptide allosteric and application thereof
08/24/2011	CN101015312B Health care functional tea for conditioning subhealthy state
08/23/2011	USRE42645 Nutritional or therapeutic compositions and methods to increase bodily glutathione levels
08/23/2011	US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/23/2011	US8003772 Chimeric PUFA polyketide synthase systems and uses thereof
08/23/2011	US8003697 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
08/23/2011	US8003679 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril
08/23/2011	US8003676 1,3,4-oxadiazole derivatives as DGAT1 inhibitors

1 ... 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 ... 1298